The current role of model-based drug development

By Suryawanshi Satyendra   Zhang Liping   Pfister Marc   Meibohm Bernd  

Expert Opinion on Drug Discovery, Vol. 5, Iss. 4, 2010-04 ,pp. : 311-321

Informa Healthcare

Access to resources Recommend Favorite

Pharmacodynamic Biomarkers in Model-Based Drug Development in Oncology

By  

Current Clinical Pharmacology, Vol. 6, Iss. 1, 2011-02 ,pp. : 30-40

Bentham Science Publishers

Access to resources Recommend Favorite

Formulation-based approach to support early drug discovery and development efforts: a case study with enteric microencapsulation dosage form development for a triarylmethane derivative TRAM-34; a novel potential immunosuppressant

By Al-Ghananeem Abeer M.   Abbassi Maggie   Shrestha Srishti   Raman Girija   Wulff  Heike   Pereira Lara   Ansari Aftab  

Drug Development and Industrial Pharmacy, Vol. 36, Iss. 5, 2010-05 ,pp. : 563-569

Informa Healthcare

Access to resources Recommend Favorite

Transferability of Model-Based Economic Evaluations: The Case of Trastuzumab for the Adjuvant Treatment of HER2-Positive Early Breast Cancer in the Netherlands

By Essers Brigitte A.B.   Seferina Shanley C.   Tjan-Heijnen Vivianne C.G.   Severens Johan L.   Novák Annoesjka   Pompen Marjolein   Oron Ulrich H.   Joore Manuela A.  

Value in Health, Vol. 13, Iss. 4, 2010-06 ,pp. : 375-380

Blackwell Publishing

Access to resources Recommend Favorite

Model-based approaches to increase efficiency of drug development in schizophrenia: a can't miss opportunity

By Nucci Gianluca   Gomeni Roberto   Poggesi Italo  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 8, 2009-08 ,pp. : 837-856

Informa Healthcare

Access to resources Recommend Favorite